Evidence map›Paper›PMID 41395978›Full record

ArticleMicrobiology spectrum2026

RND3 restricts encephalomyocarditis virus replication by promoting IKKε ubiquitination and type I interferon production.

Peng Ma, Zheng Wang, Zhengli Liu, Qi Xie, Tianxu Liu, Linjie Li

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peng Ma *College of Basic Medicine, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, China.ORCID 0000-0003-1302-0556
Zheng Wang *Key Laboratory of Bio-Resources and Eco-Environment, Animal Disease Prevention and Green Development Key Laboratory of Sichuan Province, College of Life Science, Sichuan University, Chengdu, China.
Zhengli LiuDepartment of Biochemistry and Molecular Biology, College of Basic Medicine, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan, China.
Qi XieDepartment of Biochemistry and Molecular Biology, College of Basic Medicine, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan, China.
Tianxu LiuCollege of Basic Medicine, Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, China.
Linjie LiDatong Center For Disease Control and Prevention, Datong, China.ORCID 0009-0001-8654-9859

Funding

Applied Basic Research Project of Shanxi Province, China 202403021222222National Innovation and Entrepreneurship Training Program for College Students, China 20250473PhD Start-up Foundation of Shanxi Medical University SD2356
6 · The paper itself

Abstract

Encephalomyocarditis virus (EMCV), one of the most important picornaviruses, infects many mammalian species and causes encephalitis, myocarditis, neurologic diseases, and diabetes, but the host factors that restrict infection and replication of the virus remain poorly understood. RND3, a member of the Rho GTPase family, is involved in the regulation of actin cytoskeleton dynamics, migration, and proliferation; however, its role in antiviral innate immunity is not clear. Herein, we revealed that the host restriction factor for EMCV replication, RND3, positively regulates type I interferon (IFN-I) induction. We showed that RND3 enhances the production of IFN-β and IFN-stimulated genes, leading to the attenuation of EMCV propagation. Mechanistically, RND3 specifically interacts with IκB kinase epsilon (IKK IMPORTANCE: Host cell restriction factors perform key antiviral functions during viral infection. Herein, we demonstrate that RND3 is a host restriction factor in EMCV infection that plays a role in the antiviral signaling pathway. We found that RND3 is involved in the type I IFN pathway by interacting with IKKε, which negatively regulates EMCV transmission. However, EMCV infection effectively reduces RND3 expression in cells. Collectively, these results reveal the role of RND3 in the IFN pathway and identify potential targets for controlling EMCV infection.

Indexed as

Encephalomyocarditis virusI-kappa B KinaseInterferon Type Irho GTP-Binding ProteinsVirus ReplicationAnimalsCardiovirus InfectionsCell LineHEK293 CellsHumansImmunity, InnateRibonucleoproteinsSignal TransductionUbiquitinationI-kappa B KinaseIKBKE protein, humanInterferon Type Irho GTP-Binding ProteinsRibonucleoproteinsRND3 protein, humanencephalomyocarditis virusIKKεinterferonRND3ubiquitination

Identifiers

PMID41395978
PMCPMC12889043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.